(SIML) Simlatus Corporation Recent News
(SIML) Simlatus Chairman Announces Company Subsidiary, Proscere Bioscience, Obtains $20 Mil in Initial Orders of Its CBD Coldwater Extraction System; Moves to Complete Its Manufacturing
Chairman Richard Hylen stated, “Our subsidiary, Proscere Bioscience, has recently completed its testing and will move forward with completing the manufacturing of our CBD coldwater extraction systems and initial $20M in orders. We have one of the world’s largest distributors of CBD based products wanting to move forward in purchasing of systems. This allows their global operation to produce more efficiently, with less waste and save money. This targets our $200M revenue stream for 2020 through 2023. Other revenue streams for the company include our small operations in audio/video technology for CBS, FOX, Warner Brothers and government contracting that has been a staple for the past 20 years. Our Satel division is cash positive and growing in the San Francisco metropolitan area as we contract with AT&T products for our customers. Satel has also been a staple for the past 15 years, and is gaining ground in expansion outside of San Francisco and into the Bay-Area.
“Our larger revenue stream from Proscere Bioscience will enhance our portfolio as we gain ground in the growing Cannabis industry and use our global resources.”
Simlatus Corporation New Video
Simlatus Corporation Chart
Simlatus Corporation Short Squeeze
Over the past twenty days of market trading, Simlatus Corp, from May 26, 2020 to June 23, 2020 there is a potential Short Squeeze about to happen because of an increase in short volume over the past twenty days with very little cover volume.
Because of this the Squeeze Report trend indicator issued a Short Squeeze.
For more information go to Simlatus Corporation Short Squeeze.
Another CBD related article NxGen Brands (OTCMKTS: NXGB) CBD Pet Care Products with JohnnyO